NEVVI Medicare utilization intelligence
or

← back

Provider profile

TURRENTINE, JAKE MD

Dermatology · NPI 1386934933 · HICKORY, NC

1
Groups
33
Codes · 2024
20,088
Disclosed services

TURRENTINE, JAKE is a Dermatology in HICKORY, NC, a member of 1 medical group, who billed 33 distinct codes to Medicare Part B in 2024.

Groups: SKIN SURGERY CENTER PA (WINSTON SALEM, NC)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

20,088
disclosed services
33
codes billed to Medicare Part B
Prior year · CY2023 19,193 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg
J3245 Injection, tildrakizumab, 1 mg
17003 Destruction of precancer skin growth, 2-14 growths
95044 Test for allergy using skin patch
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
11102 Biopsy of related skin growth, first growth
17000 Destruction of precancer skin growth, 1 growth
11103 Biopsy of related skin growth, each additional growth
12032 Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm
17110 Destruction of skin growth, 1-14 growths
11602 Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
11603 Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm
96372 Injection of drug or substance under skin or into muscle
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
69100 Biopsy of ear
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
12034 Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 7.6-12.5 cm
11402 Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm
12042 Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm
17004 Destruction of precancer skin growth, 15 or more growths
17261 Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
11622 Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm
96567 Application of light to destroy precancer skin growth
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
11604 Removal of cancer skin growth of body, arms, or legs, 3.1-4.0 cm
12052 Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm
11104 Punch biopsy, first skin growth
11642 Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm
11403 Removal of noncancer skin growth of body, arms, or legs, 2.1-3.0 cm
11900 Injection into skin growth, 1-7 growths
11623 Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.